Canaan Inc. Sponsored ADR CAN
0.38
(0.01)
(2.56%)
as of 25 Sep
- Market cap
- $288.6M
- P/E
- 0.0×
Follow CAN
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
0.48 | 0.58 | 0.61 | 1.08 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(4.04) | (1.10) | (1.19) | (2.29) | |
P/B ratio |
0.72 | 0.78 | 0.74 | 1.20 | |
Price to Tangible BV |
0.72 | 0.78 | 0.74 | 1.21 | |
EV/Sales |
0.46 | 0.61 | 0.56 | 0.91 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(0.36) | (0.55) | (0.53) | (0.96) | |
EV/FCF |
(0.33) | (0.50) | (0.48) | (0.89) | |
Quick Ratio |
0.91 | 1.15 | 1.17 | 0.86 | |
Current Ratio |
2.86 | 3.34 | 3.31 | 1.85 | |
Net Debt/EBITDA |
0.15 | (0.21) | 1.95 | 3.22 | |
Debt/Assets |
13.17% | 10.37% | 8.67% | 6.86% | |
Debt/Equity |
0.20 | 0.14 | 0.12 | 0.12 | |
Asset Turnover |
0.85 | 0.93 | 0.99 | 0.72 | |
Operating CF/Net income |
0.53 | 0.00 | 3.19 | 0.00 | |
Capex/Depreciation |
0.00 | — | (0.50) | — | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
46.65% | 24.55% | 5.84% | 10.86% | |
Selling, General and Administrative Expense of Revenue |
53.32% | 25.86% | 9.16% | 15.29% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 11.62% | 0.00% | |
Graham Net Nets |
0.75 | 0.69 | 0.83 | 0.50 | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
(151.72%) | (79.07%) | (69.57%) | (77.27%) | |
Free Cash Flow Yield |
(292.18%) | (208.40%) | (191.25%) | (94.08%) | |
Revenue per Share |
0.04 | 0.09 | 0.42 | 0.29 | |
Operating CF per Share |
(0.07) | 0.00 | (0.58) | 0.00 | |
Capex per Share |
0.00 | 0.00 | (0.05) | 0.00 | |
Free Cash Flow per Share |
(0.07) | 0.00 | (0.63) | 0.00 | |
Cash per Share |
0.09 | 0.06 | 0.17 | 0.23 | |
Shareholders Equity per Share |
0.40 | 0.55 | 0.93 | 0.73 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
0.40 | 0.55 | 0.93 | 0.73 | |
Free Cash Flow |
(53.64) | — | (295.14) | — | |
Working Capital |
202.06 | 249.49 | 302.20 | 238.40 | |
Capital Expenditures |
(1.71) | — | (23.93) | — | |
Net Current Asset Value |
157.02 | 205.78 | 267.77 | 227.26 | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.05 | 0.00 | 0.12 | 0.00 | |
Net Profit Margin |
(306.34%) | (141.56%) | (43.32%) | (18.44%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Receivables |
55.07 | 70.59 | 62.01 | 64.89 | |
Average Payables |
22.71 | 18.07 | 19.79 | 25.20 | |
Average Inventory |
118.39 | 126.47 | 137.72 | 144.77 | |
Average Assets |
519.21 | 548.80 | 532.95 | 586.07 | |
Average Common Equity |
308.15 | 313.78 | 351.81 | 347.85 |
Columns are period end dates